Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 292

1.

Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.

Gupta M, Bhatnagar P, Grover S, Kaur H, Baghel R, Bhasin Y, Chauhan C, Verma B, Manduva V, Mukherjee O, Purushottam M, Sharma A, Jain S, Brahmachari SK, Kukreti R.

Pharmacogenomics. 2009 Mar;10(3):385-97. doi: 10.2217/14622416.10.3.385.

PMID:
19290789
2.

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.

Kocabas NA, Faghel C, Barreto M, Kasper S, Linotte S, Mendlewicz J, Noro M, Oswald P, Souery D, Zohar J, Massat I.

Int Clin Psychopharmacol. 2010 Jul;25(4):218-27. doi: 10.1097/YIC.0b013e328338b884.

PMID:
20531207
3.
4.

Association between a COMT polymorphism and clinical response to risperidone treatment: a pharmacogenetic study.

Zhao QZ, Liu BC, Zhang J, Wang L, Li XW, Wang Y, Ji J, Yang FP, Wan CL, Xu YF, Feng GY, He L, He G.

Psychiatr Genet. 2012 Dec;22(6):298-9. doi: 10.1097/YPG.0b013e328358629a.

PMID:
22935916
5.

Impact of catechol-o-methyltransferase polymorphisms on risperidone treatment for schizophrenia and its potential clinical significance.

Gao S, Hu Z, Cheng J, Zhou W, Xu Y, Xie S, Liu S, Li Z, Guo J, Dong J, Huang M.

Clin Biochem. 2012 Jul;45(10-11):787-92. doi: 10.1016/j.clinbiochem.2012.04.016. Epub 2012 Apr 27.

PMID:
22560999
6.

Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.

Gupta M, Chauhan C, Bhatnagar P, Gupta S, Grover S, Singh PK, Purushottam M, Mukherjee O, Jain S, Brahmachari SK, Kukreti R.

Pharmacogenomics. 2009 Feb;10(2):277-91. doi: 10.2217/14622416.10.2.277.

PMID:
19207030
7.

Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia.

Handoko HY, Nyholt DR, Hayward NK, Nertney DA, Hannah DE, Windus LC, McCormack CM, Smith HJ, Filippich C, James MR, Mowry BJ.

Mol Psychiatry. 2005 Jun;10(6):589-97.

PMID:
15505638
8.

Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.

Chen CY, Yeh YW, Kuo SC, Ho PS, Liang CS, Yen CH, Lu RB, Huang SY.

Psychoneuroendocrinology. 2016 Mar;65:67-75. doi: 10.1016/j.psyneuen.2015.12.003. Epub 2015 Dec 8.

PMID:
26724569
9.

No associations exist between five functional polymorphisms in the catechol-O-methyltransferase gene and schizophrenia in a Japanese population.

Nunokawa A, Watanabe Y, Muratake T, Kaneko N, Koizumi M, Someya T.

Neurosci Res. 2007 Jul;58(3):291-6. Epub 2007 Apr 7.

PMID:
17482701
10.

Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia.

Fijal BA, Kinon BJ, Kapur S, Stauffer VL, Conley RR, Jamal HH, Kane JM, Witte MM, Houston JP.

Pharmacogenomics J. 2009 Oct;9(5):311-8. doi: 10.1038/tpj.2009.24. Epub 2009 May 19.

PMID:
19451915
11.

HapMap tag-SNP analysis confirms a role for COMT in schizophrenia risk and reveals a novel association.

Voisey J, Swagell CD, Hughes IP, Lawford BR, Young RM, Morris CP.

Eur Psychiatry. 2012 Jul;27(5):372-6. doi: 10.1016/j.eurpsy.2010.08.004. Epub 2010 Oct 8.

PMID:
20934310
12.

Analysis of association between the catechol-O-methyltransferase (COMT) gene and negative symptoms in chronic schizophrenia.

Wang Y, Fang Y, Shen Y, Xu Q.

Psychiatry Res. 2010 Sep 30;179(2):147-50. doi: 10.1016/j.psychres.2009.03.029. Epub 2010 May 18.

PMID:
20483479
13.

COMT gene haplotypes are closely associated with postoperative fentanyl dose in patients.

Zhang F, Tong J, Hu J, Zhang H, Ouyang W, Huang D, Tang Q, Liao Q.

Anesth Analg. 2015 Apr;120(4):933-40. doi: 10.1213/ANE.0000000000000563.

PMID:
25532715
14.

Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone.

Yamanouchi Y, Iwata N, Suzuki T, Kitajima T, Ikeda M, Ozaki N.

Pharmacogenomics J. 2003;3(6):356-61.

PMID:
14610521
15.

Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families.

Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS.

Mol Psychiatry. 2004 Oct;9(10):962-7.

PMID:
15124004
16.

Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.

Weickert TW, Goldberg TE, Mishara A, Apud JA, Kolachana BS, Egan MF, Weinberger DR.

Biol Psychiatry. 2004 Nov 1;56(9):677-82.

PMID:
15522252
17.

The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.

Bialecka M, Kurzawski M, Klodowska-Duda G, Opala G, Tan EK, Drozdzik M.

Pharmacogenet Genomics. 2008 Sep;18(9):815-21. doi: 10.1097/FPC.0b013e328306c2f2.

PMID:
18698234
18.

Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults.

Halleland H, Lundervold AJ, Halmøy A, Haavik J, Johansson S.

Am J Med Genet B Neuropsychiatr Genet. 2009 Apr 5;150B(3):403-10. doi: 10.1002/ajmg.b.30831.

PMID:
18802928
19.

Association analysis of COMT polymorphisms and schizophrenia in a Chinese Han population: a case-control study.

Yu R, Zhang XN, Huang XX, Ding SP, Li JC.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):570-3.

PMID:
17427186
20.

Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.

Sweet RA, Devlin B, Pollock BG, Sukonick DL, Kastango KB, Bacanu SA, Chowdari KV, DeKosky ST, Ferrell RE.

Mol Psychiatry. 2005 Nov;10(11):1026-36.

PMID:
16027741

Supplemental Content

Support Center